drugset
drugset / Trial / NCT00729729

Pharmacokinetic Study for PCA Derivate Formulations

NCT00729729 ↗

Phase 4 Completed 30 enrolled Hadassah Medical Organization
RandomizedCrossoverQuadruple-blind

Summary

A comparative bioavailability study of PCA slow release versus immediate release formulations, after a single dose to fasting healthy subjects.

Timeline

Start
2008-07
Primary completion
2009-02
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject PCA Unknown 700 mg Oral
Subject PCA Unknown 1000 mg Oral

Indications

No indication recorded.